NCT01605097View on ClinicalTrials.gov

High Dose Rate Prostate Brachytherapy: Dose Escalation to Dominant Intra-prostatic Nodule

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2018

Conditions
Prostate Cancer
Interventions
RADIATION

HDR interstitial brachytherapy

2 treatments of 1000 cGy will be delivered to the entire prostate volume while escalating the dose to the visible disease to 1250 cGy

Trial Locations (1)

V1Y5L3

Cancer Center for the Southern Interior, Kelowna

All Listed Sponsors
lead

British Columbia Cancer Agency

OTHER

NCT01605097 - High Dose Rate Prostate Brachytherapy: Dose Escalation to Dominant Intra-prostatic Nodule | Biotech Hunter | Biotech Hunter